Guillain–Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy syndrome. Several genetic and environmental risk factors have been recognized for GBS. AS GBS is an …
This study aimed at identifying human neural proteins that can be attacked by cross-reacting SARS-COV-2 antibodies causing Guillain-Barré syndrome. These markers can be used for …
Guillain-Barré syndrome (GBS) is an autoimmune disease in which the peripheral nerves are affected. GBS has different subtypes, such as acute inflammatory demyelinating …
Y Zhao, R Zhu, D Tian, X Liu - Autoimmunity Reviews, 2020 - Elsevier
Abstract Objective Guillain-Barré Syndrome (GBS) is considered to be a complex immune- mediated neuropathy. In the past few years, numerous studies were performed to detect the …
Immune-mediated demyelinating polyneuropathies (IMDPs) are rare disorders in which dysregulated adaptive immune responses cause peripheral nerve demyelinating …
Complement activation plays a critical role in the pathogenesis of Guillain-Barré syndrome (GBS), a debilitating immune-mediated neuropathy. Mannose-binding lectin (MBL) is a …
Guillain-Barré syndrome (GBS) is an immune-mediated neurological disorder with a multifaceted nature. Infectious agents and immune-response genetic host factors may …
EE Ubogu, JA Conner, Y Wang, D Yadav, TL Saunders - bioRxiv, 2023 - biorxiv.org
Introduction: Major histocompatibility complex (MHC) class II professional antigen presenting cell-naive CD4+ T cell interactions via the T-cell receptor complex are necessary …
Abstract Objective Guillain‐Barré syndrome (GBS) is a rare, life‐threatening disorder of the peripheral nervous system. Immunoglobulin G Fc‐gamma receptors (FcγRs) mediate and …